quinoxalines has been researched along with Prostatic Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Cashman, JR; Cheng, J; Gomez-Galeno, J; Lee, DH; Moore, S; Okolotowicz, KJ | 1 |
| Ferraz, R; Jerónimo, C; Marques-Magalhães, Â; Miranda-Gonçalves, V; Prudêncio, C; Silva, RA; Vieira, FQ; Vieira, M | 1 |
| Battaglia, S; Cortes Gomez, E; Gillard, B; Karasik, E; Koya, RC; Lugade, A; Matsuzaki, J; Odunsi, K; Singh, PK; Thorne, JL; Tsuji, T; Want, MY | 1 |
| Bhardwaj, G; Changou, C; Evans, CP; Feng, C; Guo, W; Huang, W; Kung, HJ; Lam, KS; Li, Y; Liu, R; Luo, Y; Ma, AH; Mazloom, A; Patterson, R; Sanchez, E; Wang, Y; Yang, JC | 1 |
| Bhardwaj, G; Changou, C; Chintapalli, S; Evans, CP; Guo, W; Kumaresan, P; Kung, HJ; Lam, KS; Liu, R; Ma, AH; Mazloom, A; Patterson, R; Sanchez, E; Xiao, K; Xiao, W; Yang, JC; Yeh, CT | 1 |
| Adisetiyo, H; Garofalo, A; Grande, F; Neamati, N; Roy-Burman, P; Tamura, S; Xu, S | 1 |
| Colapietro, A; Festuccia, C; Gravina, GL; Jitariuc, A; Mancini, A; Marampon, F; Ricevuto, E; Scarsella, L; Vitale, F | 1 |
| Giovannucci, EL; Nimptsch, K; Platz, EA; Rohrmann, S; Sinha, R; Willett, WC; Wu, K | 1 |
| Imada, K; Inokuchi, J; Itsumi, M; Kuruma, H; Naito, S; Oda, Y; Shiota, M; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A | 1 |
| Niu, Y; Ping, H; Wang, M; Xing, N; Yang, F | 1 |
| Hong, JH; Kim, DK; Kim, IY; Kim, SJ; Kwak, C; Lee, GT; Mueller, TJ; Sheen, YY; Watson, JA | 1 |
| Brown, K; Liu, W; Moore, RB; Owen, RJ; Tulip, J; Woo, T; Xiao, Z | 1 |
| Cronauer, MV; Jain, G; Marienfeld, RB; Möller, P; Spindler, KD; Tobias, A; Voogdt, C | 1 |
| Barnett, SF; Defeo-Jones, D; Fu, S; Hancock, PJ; Haskell, KM; Huber, HE; Jones, RE; Kahana, JA; Kral, AM; Leander, K; Lee, LL; Malinowski, J; McAvoy, EM; Nahas, DD; Robinson, RG | 1 |
| Andriole, GL; Cross, AJ; Hayes, RB; Kirsh, VA; Peters, U; Reding, D; Sinha, R | 1 |
| Dorr, RT; Landowski, TH; Pourpak, A | 1 |
| Alavanja, MC; Cross, AJ; Hoppin, JA; Koutros, S; Ma, X; Sandler, DP; Sinha, R; Zheng, T | 1 |
| Jongsma, J; Noordzij, MA; Oomen, MH; Romijn, JC; Schröder, FH; van Der Kwast, TH; van Steenbrugge, GJ | 1 |
| Archer, CL; Haas, GP; Jones, RF; Morse, P; Shirai, T; Wang, CY | 1 |
1 trial(s) available for quinoxalines and Prostatic Neoplasms
| Article | Year |
|---|---|
A prospective study of meat and meat mutagens and prostate cancer risk.
Topics: Aged; Benzo(a)pyrene; Cooking; Diet; Humans; Imidazoles; Male; Meat; Middle Aged; Mutagens; Prospective Studies; Prostatic Neoplasms; Quinoxalines; Risk Factors; Surveys and Questionnaires | 2005 |
18 other study(ies) available for quinoxalines and Prostatic Neoplasms
| Article | Year |
|---|---|
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspartate Aminotransferases; Benzamides; Cell Line, Tumor; Drug Synergism; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Piperazines; Prostatic Neoplasms; Quinoxalines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |
The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines.
Topics: Ampicillin; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Ionic Liquids; Male; Prostatic Neoplasms; Pyridinium Compounds; Quinoxalines | 2020 |
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphocytes, Tumor-Infiltrating; Male; Methylation; Mice; Mice, Transgenic; Neoplasm Transplantation; Prognosis; Prostatic Neoplasms; Quinoxalines; Repressor Proteins; Sequence Analysis, RNA; Survival Analysis; Tumor Microenvironment | 2021 |
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Benzofurans; Binding Sites; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Models, Molecular; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Conformation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Quinoxalines; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2013 |
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Autophagy; Binding Sites; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Imidazoles; Male; Mice; Mice, Nude; Molecular Docking Simulation; Phospholipase C gamma; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Quinoxalines; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Taxoids; Transplantation, Heterologous | 2014 |
Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prostatic Neoplasms; PTEN Phosphohydrolase; Quinoxalines; Survivin | 2015 |
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Forkhead Box Protein O1; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Male; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Quinoxalines; Receptors, Androgen; RNA, Small Interfering; Sirolimus; Sulfonamides; TOR Serine-Threonine Kinases | 2016 |
Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals.
Topics: Adult; Aged; Benzimidazoles; Cooking; Feeding Behavior; Follow-Up Studies; Health Personnel; Humans; Imidazoles; Incidence; Male; Meat; Middle Aged; Mutagens; Prostatic Neoplasms; Quinoxalines; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; United States | 2015 |
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Topics: Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Combined Modality Therapy; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nuclear Proteins; Orchiectomy; Prostatic Neoplasms; Quinoxalines; Random Allocation; Receptors, Androgen; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Twist-Related Protein 1; Xenograft Model Antitumor Assays | 2015 |
IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; I-kappa B Kinase; Imidazoles; In Situ Nick-End Labeling; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinoxalines; Signal Transduction | 2016 |
Effect of IN-1130, a small molecule inhibitor of transforming growth factor-beta type I receptor/activin receptor-like kinase-5, on prostate cancer cells.
Topics: Animals; Drug Screening Assays, Antitumor; Humans; Imidazoles; Male; Mice; Prostatic Neoplasms; Quinoxalines; Tumor Cells, Cultured | 2008 |
Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
Topics: Animals; Dogs; Infusions, Intra-Arterial; Liposomes; Male; Molecular Structure; Perylene; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Quinoxalines | 2010 |
IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines.
Topics: Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Gene Silencing; Humans; I-kappa B Kinase; Imidazoles; Male; Prostatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Protein Transport; Quinoxalines; Receptors, Androgen; Signal Transduction | 2012 |
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adenosine Triphosphate; Apoptosis Regulatory Proteins; Benzylamines; Binding, Competitive; Blood Proteins; Carcinoma; Caspases; Cell Line, Tumor; Cloning, Molecular; Enzyme Activation; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Humans; Isoenzymes; Male; Membrane Glycoproteins; Molecular Structure; Peptides; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinoxalines; Sequence Homology, Amino Acid; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2005 |
Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Catenated; DNA, Kinetoplast; Docetaxel; Humans; Isoquinolines; Male; Melphalan; Mice; Mice, SCID; Mitoxantrone; Naphthalimides; Prostatic Neoplasms; Protein Binding; Quinoxalines; RNA Interference; Taxoids; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays | 2007 |
Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study.
Topics: Case-Control Studies; Cohort Studies; Cooking; Diet; Humans; Male; Meat; Middle Aged; Mutagens; Polycyclic Aromatic Hydrocarbons; Prospective Studies; Prostatic Neoplasms; Quinoxalines | 2008 |
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
Topics: Androgens; Cell Division; Cyclic AMP; Dideoxyadenosine; Enzyme Inhibitors; Gastrin-Releasing Peptide; Humans; Male; Neuropeptides; Oxadiazoles; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Thymidine; Tumor Cells, Cultured | 2000 |
Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the rat.
Topics: Aminobiphenyl Compounds; Animals; Animals, Newborn; Body Weight; Carcinogens; Carcinoma, Transitional Cell; Colonic Neoplasms; Hyperplasia; Imidazoles; Male; Mutagens; Prostatic Neoplasms; Pyridines; Quinoxalines; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms | 2000 |